Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 9:06 PM
Ignite Modification Date: 2025-12-24 @ 9:06 PM
NCT ID: NCT01188304
Eligibility Criteria: Inclusion Criteria: * Healthy volunteers, aged 40 to 65 years inclusive * Body Mass Index (BMI) between 18 and 35 kg/m2 inclusive * Females of child-bearing potential must be willing to use two acceptable methods of contraception during the study and at least 3 months before start of the study * Non-smoker or currently smoking less than 5 cigarettes (or equivalent amount of other tobacco products) per day and is willing and able to stop smoking during the period in study center * Volunteer drinks no more than 3 cups of coffee, tea or soft drinks per day and is willing and able to stop drinking coffee, tea and soft drinks during the period in study center Exclusion Criteria: * Any clinically relevant abnormal laboratory test results at screening * Volunteer has taken any prescribed, herbal or over-the-counter medication within 2 weeks prior to first dosing * A history of any clinical significant gastro-intestinal, cardiovascular, musculoskeletal, endocrine, hematological, psychiatric, renal, hepatic, bronchopulmonary or neurological conditions or lipid disorders * A positive test for human immunodeficiency virus (HIV-1 or HIV-2), hepatitis B or hepatitis C * History of intolerance to non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin, history of gastric or duodenal ulceration, personal or family history of abnormal clotting or bleeding
Healthy Volunteers: True
Sex: ALL
Minimum Age: 40 Years
Maximum Age: 65 Years
Study: NCT01188304
Study Brief:
Protocol Section: NCT01188304